Search / Trial NCT06224517

Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation

Launched by SHIN KONG WU HO-SU MEMORIAL HOSPITAL · Jan 16, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Ischemic Stroke Arterial Stiffness Pulse Wave Velocity Rehabilitation

Description

Objectives: The purpose of this study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation between these changes and functional recovery. Background: Arterial stiffness, increasing with age, is a significant risk factor for atherosclerotic diseases and a predictor of mortality from various causes, including symptomatic strokes. The brachial-ankle pulse wave velocity (baPWV), a reliable measure of arterial stiffness, correlates with cardiovascular events and mortality risk. Clinical improvements post-ischemic stroke align with a decre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * First-onset cerebral ischemic stroke within the previous 3 months, which is confirmed clinically by computed tomography scans or magnetic resonance imaging
  • * Sufficient cognition to understand procedures and provide informed consent.
  • Exclusion Criteria:
  • * Hemorrhagic stroke, cerebellar or brainstem lesions which may affect autonomic or balance
  • * Concurrent neurological or neurodegenerative diseases (e.g. Parkinson's disease, multiple sclerosis, etc.)
  • * Brain tumor
  • * Malignancy
  • * Limb deficiency or amputation

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Taipei City, , Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0